As the acute phase of the COVID-19 public health emergency ends, there is a unique opportunity to leverage pandemic-related flexibilities and technological advancements to improve care delivered outside of the clinical setting. Health care organizations and policymakers have an essential role to play in supporting, advancing and facilitating the future of “HealthCare Without an Address.”

There is a persistent disparity in access to health care around the world, regardless of how health care is structured, delivered, and financed. Within each country, there are people who are medically underserved and are more likely to face inequitable access to care.
Which strategies,models, and policy options can be implemented by leaders of care delivery organizations and policymakers to improve equitable access to care?

Health systems play critical roles in their communities as healthcare providers, employers and purchasers. As such health systems represent powerful stakeholders, partners and influencers of public policy in their communities. Still, vital gaps remain between clinical care and community services that would address social determinants of health (SDOH) and health-related social needs (HRSN).

Innovations that contribute clear benefits beyond the regular standard of treatment are at the heart of the future of healthcare. Yet, while the healthcare industry can be very innovative it is also perceived to be bureaucratic and slow in the adoption and diffusion of innovations, particularly when compared to other industries. Who are the Agents of Change? Which factors are most likely to prevent the adoption of innovation beyond pilots and individual efforts?